Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Insulin for Prevention of Postoperative Delirium in Older Patients With Type 2 Diabetes
NCT07720479Not yet recruiting
- Sponsor
- Weidong Mi
- Start
- Jul 2026
- Primary completion
- Feb 2028
01
Overview
Randomised, double-blind trial of Generex Oral-lyn in postoperative delirium (POD) (3 arms), sponsored by Weidong Mi. Primary endpoint: Postoperative Delirium. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
Generex Oral-lyn
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT07720479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07720479.